Clinical Trial

Intermittent Cold Exposure and Brown Adipose Tissue Hyperplasia

Study acronym: ICEBATH
Recruiting
View on ClinicalTrials.gov →
Summary
This clinical trial explores how repeated short-term cold exposure impacts the molecular and physiological function of brown adipose tissue (BAT), a thermogenic organ associated with improved cardiometabolic health. While intermittent cold exposure has been shown to increase BAT activity and mass, as measured by fluorodeoxyglucose (18F-FDG) uptake on positron emission tomography/computed tomography (PET/CT) scans, the molecular adaptations within BAT and other thermogenic tissues including skeletal muscle and white adipose tissue (WAT) remain poorly understood. Healthy adults aged 18 to 40 years (6 males and 6 females) will participate in a 10-day cold acclimation protocol (2 hours per day using water-perfused cooling blankets). The primary objective is to determine how cold exposure alters cellular heterogeneity and gene expression in BAT, WAT, and skeletal muscle. Participants will undergo baseline assessments, including measurements of energy expenditure, core and skin temperature, muscle activity, and blood sampling, each performed in both warm and cold conditions. These assessments will be followed by dynamic total-body PET/CT imaging during cold exposure and tissue biopsies from BAT, subcutaneous WAT, and skeletal muscle. These procedures will be repeated after the cold acclimation protocol to evaluate physiological and molecular changes. Additional outcomes include changes in energy expenditure, cold tolerance, and immune cell responses induced by cold exposure.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-07 -> 2027-07 2026-07-01
minor Completion pushed: 2026-07 -> 2027-07 2026-07-01
Trial Details
NCT Number NCT07048405
Lead Sponsor University of Edinburgh
Conditions Brown Adipose Tissue, Cold Exposure, 18F-FDG PET/CT
Enrollment 12 participants
Start Date 2025-05-01
Primary Completion 2027-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-06-30